© Brighteon.com All Rights Reserved. All content posted on this site is commentary or opinion and is protected under Free Speech. Brighteon is not responsible for comments and content uploaded by our users.
This channel has partnered with the Brighteon Store and receives a small commission from all sales generated from an affiliate link.
Click the shop now button below to help out this channel.
https://gnews.org/articles/509962
摘要:On November 2nd, Swedish public health authority paused inoculation of the EU-approved mRNA vaccine Nuvaxovid, and stated that the vaccine increases the risk of myocarditis for population under 30, citing an Australian research report





